Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s): QNTM

Healthcare

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

CSE:QNTM - Post by User

Quantum BioPharma Ltd > FSD Pharma Morningstar Fair Value $3.23 USD

<< Previous

Bullboard Posts

Next >>

Comment by Renofundon Jun 14, 2022 7:54am

127 Views

Post# 34754328

RE:FSD Pharma Morningstar Fair Value $3.23 USD

JensLens wrote: https://docdro.id/qUAE6ur

now pumping lower target prices haha. For those who may not be aware, this works out to roughly $0.016 (1.6 cents) pre-split. Destruction of capital thus far.

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks